ONC – beone medicines ltd. - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ONC

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/18

10:27 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

11/18

10:27 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

11/10

04:29 pm

onc

Rating for ONC

Medium Report

Rating for ONC

Report

11/10

04:29 pm

onc

Rating for ONC

Medium Report

Rating for ONC

Report

11/7

01:16 pm

onc

Rating for ONC

Low Report

Rating for ONC

Report

11/7

01:16 pm

onc

Rating for ONC

Low Report

Rating for ONC

Report

10/20

11:24 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

10/20

11:24 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

10/20

11:15 am

onc

BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

10/20

11:15 am

onc

BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

BeOne Medicines (NASDAQ:ONC) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

10/8

01:29 pm

onc

Rating for ONC

Low Report

Rating for ONC

Report

9/18

08:09 am

onc

BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $385.00 price target on the stock.

Low Report

BeOne Medicines (NASDAQ:ONC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $385.00 price target on the stock.

Report

9/18

07:16 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

9/18

07:16 am

onc

Rating for ONC

Low Report

Rating for ONC

Report

9/18

04:34 am

onc

BeOne Medicines initiated with an Overweight at Barclays

Medium Report

BeOne Medicines initiated with an Overweight at Barclays

Report

9/18

04:34 am

onc

BeOne Medicines initiated with an Overweight at Barclays

Medium Report

BeOne Medicines initiated with an Overweight at Barclays

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.